Adial Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $5.9M | $3.8M | $2.8M | $4.0M | $6.1M | $4.4M | $6.8M | $3.9M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $6.2M | $4.1M | $3.2M | $4.8M | $6.5M | $5.1M | $7.7M | $4.7M |
| Property, Plant & Equipment | — | — | — | $50.4K | $58.1K | — | — | — |
| Goodwill | — | — | — | $249.0K | $249.0K | — | — | — |
| Intangible Assets (Excl. Goodwill) | $2.8K | $3.3K | $3.9K | $4.5K | $5.0K | $5.6K | $6.2K | $6.7K |
| Total Assets | $6.7M | $5.0M | $4.7M | $5.7M | $7.5M | $5.5M | $7.7M | $4.7M |
| Liabilities | ||||||||
| Accounts Payable | $655.2K | $250.1K | $103.3K | $276.4K | $286.2K | $648.7K | $190.2K | $99.7K |
| Total Current Liabilities | $1.4M | $975.9K | $653.1K | $1.8M | $2.7M | $1.5M | $539.1K | $258.0K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $1.4M | $975.9K | $653.1K | $2.5M | $4.0M | $1.5M | $539.1K | $258.0K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-90.0M | $-82.0M | $-68.8M | $-63.7M | $-50.9M | $-31.5M | $-20.6M | $-12.0M |
| Total Stockholders' Equity | $5.3M | $4.1M | $4.1M | $3.3M | $3.5M | $4.0M | $7.1M | $4.4M |